Unibio CIS ApS: Financial statements 2017
CVR: 37456136
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Unibio CIS ApS (CVR 37456136) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 94,000 and a net result of DKK 18,000 compared with DKK 237,000 the year before. That is a decrease of 66.3% compared with the year before. Equity in the 2017 report amounted to DKK 305,000. The solvency ratio was 13.4%.
- Gross Profit
- DKK 94,000
- Profit/Loss
- DKK 18,000
- Equity
- DKK 305,000
- Total Assets
- DKK 2,276,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 94 t. | 18 t. | 305 t. | - |
| 2016 | - | 279 t. | 237 t. | 287 t. | - |
Official annual report
Keep an eye on Unibio CIS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of August 31, 2017, Leif Jacobsen has stepped down as director of Unibio CIS ApS.
Unibio CIS ApS has published its interim report for the period February 11, 2016 – December 31, 2016.
About Unibio CIS ApS
Unibio CIS ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named UniBio Russia ApS. The management consists of Søren Olrik Eklund and Jess Dragheim. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,100,000 and a net result of DKK 2,068,000 compared with DKK -2,197,000 the year before. Equity in the 2025 report amounted to DKK 2,417,000.